Photodynamic Therapy Combined With Bevacizumab vs Bevacizumab Alone for Neovascular Age-related Macular Degeneration

NCT00696592 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped new data from clinical trials

Conditions

Neovascular Age-related Macular Degeneration

Interventions

DRUG: Bevacizumab (Avastin), Verteporfin (Visudyne)

Sponsor

University of Padova

Collaborators

[object Object]